文献速递腹部泌尿生殖USCTMR

直肠内对比剂充盈后腹部超声在严重狭窄性结直肠癌中的价值

Abdominal Ultrasonography After Transrectal Filling With Contrast Agents in Colorectal Cancer With Severely Stenotic Lesions.
PubMed 文献 · Ultrasound Med Biol · 2023-07-08

回顾性纳入83例因严重肠腔狭窄而结肠镜检查失败的结直肠癌患者,术前2周行直肠内对比剂充盈后腹部超声(AU-TFCA)及增强CT和/或MRI,以术后病理为参考标准。AU-TFCA的T分期与病理一致性(线性加权κ=0.558,p<0.001)优于增强CT/MRI(κ=0.237,p<0.001),T分期总准确率83.1%显著高于增强CT/MRI的50.6%;病变长度AU-TFCA与病理相当(t=1.852,p=0.068),而增强CT/MRI与病理差异显著(t=8.450,p<0.001)。

要点

  • AU-TFCA的T分期总准确率83.1%,显著高于增强CT/MRI的50.6%。
  • AU-TFCA的T分期与病理一致性线性加权κ=0.558(p<0.001),增强CT/MRI为κ=0.237(p<0.001)。
  • 病变长度AU-TFCA与病理相当(t=1.852,p=0.068),增强CT/MRI与病理差异显著(t=8.450,p<0.001)。

核心结论

  • AU-TFCA可有效评估严重狭窄性结直肠癌病变的长度和T分期,其诊断准确率显著优于增强CT/MRI。

研究设计与样本

  • 回顾性研究,纳入83例因严重肠腔狭窄而结肠镜检查失败的结直肠癌患者,术前2周行AU-TFCA及增强CT和/或MRI,以术后病理结果为参考标准。

诊断标准与关键数值

  • T分期与术后病理一致性:AU-TFCA线性加权κ=0.558(p<0.001),增强CT/MRI线性加权κ=0.237(p<0.001)。
  • T分期总诊断准确率:AU-TFCA 83.1%,增强CT/MRI 50.6%,AU-TFCA显著高于增强CT/MRI。
  • 病变长度与病理比较:AU-TFCA与病理相当(t=1.852,p=0.068),增强CT/MRI与病理差异显著(t=8.450,p<0.001)。

临床应用与阅片要点

  • 对因严重肠腔狭窄而结肠镜检查失败的结直肠癌患者,可考虑采用AU-TFCA评估T分期和病变长度。
  • AU-TFCA的T分期诊断准确率(83.1%)显著高于增强CT/MRI(50.6%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Abdominal ultrasonography after transrectal filling with contrast agent (AU-TFCA) was retrospectively evaluated with respect to determination of T stage and lesion length in patients with colorectal cancer (CRC) who had previously failed colonoscopy because of severe intestinal stenosis.

METHODS: The population comprised 83 patients with CRC with intestinal stenosis and previously failed colonoscopy who underwent AU-TFCA, and in addition contrast-enhanced computed tomography (CECT) and/or magnetic resonance imaging (MRI), 2 wk before surgery. The diagnostic performance of AU-TFCA and CECT/MRI was evaluated relative to the post-operative pathological results (PPRs) by paired sample t-test, receiver operator characteristic (ROC) curve, Pearson's χ2-test and κ and intraclass correlation coefficients.

RESULTS: The T staging identified via AU-TFCA, but not CECT/MRI, was relatively consistent with that of the PPRs (linearly weighted κ coefficient: 0.558, p < 0.001, and linearly weighted κ coefficient: 0.237, p < 0.001, respectively). The overall diagnostic accuracy of T staging based on AU-TFCA (83.1%) was significantly higher than that based on CECT/MRI (50.6%). Regarding lesion length, the results of AU-TFCA and PPRs were comparable (t = 1.852, p = 0.068), but those of CECT/MRI and PPRs were significantly different (t = 8.450, p < 0.001).

CONCLUSION: AU-TFCA is effective in evaluation of lesion length and T stage in patients with severely stenotic CRC lesions who previously failed colonoscopy. The diagnostic accuracy of AU-TFCA is significantly better compared with that of CECT/MRI.

来源:Ultrasound Med Biol,查看原文。版权归原作者所有。

引用

  1. Zhong Y, Jian GL, Li QX, et al. Abdominal Ultrasonography After Transrectal Filling With Contrast Agents in Colorectal Cancer With Severely Stenotic Lesions. Ultrasound Med Biol. 2023. PMID: 37423829. doi:10.1016/j.ultrasmedbio.2023.06.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。